February 13, 2004 Myeloma Minute

By IMF Admin on September 26, 2011 10:28 PM | No Comments

Bank On A Cure

By IMF Admin on September 26, 2011 10:20 PM | No Comments

Bank On A Cure

Afternoon Tea in Washington DC

By IMF Admin on September 26, 2011 10:19 PM | No Comments

Afternoon Tea in Washington DC

IMF 5th Annual Comedy Celebration
benefiting the Peter Boyle Memorial Fund

By IMF Admin on September 22, 2011 10:09 PM | 2 Comments

IMF 5th Annual Comedy Celebration
benefiting the Peter Boyle Memorial Fund

September 4, 2002 IMF Myeloma Minute

By IMF Admin on September 22, 2011 2:03 AM | No Comments

September 4, 2002 IMF Myeloma Minute

Advocacy Update - September 16, 2011

By IMF Admin on September 22, 2011 1:09 AM | No Comments

Advocacy Update - September 16, 2011

ESTADIFICACI

By IMF Admin on September 20, 2011 2:38 AM | No Comments

ESTADIFICACI

Multiple Myeloma Awareness Week 2002!

By IMF Admin on September 19, 2011 12:43 PM | No Comments

Multiple Myeloma Awareness Week 2002!

March 14, 2002: IMF Myeloma Minute Special Report

By IMF Admin on September 19, 2011 12:35 PM | No Comments

March 14, 2002: IMF Myeloma Minute Special Report

New Therapies

By IMF Admin on September 19, 2011 10:58 AM | No Comments

New Therapies

An Overview of ASH 2006

By IMF Admin on September 19, 2011 3:32 AM | No Comments

An Overview of ASH 2006

Harold Hayden

By IMF Admin on September 19, 2011 2:28 AM | No Comments

Harold Hayden

Michael Smith

By IMF Admin on September 19, 2011 2:14 AM | No Comments

Michael Smith

Help Us Learn More About Myeloma Patients

By IMF Admin on September 18, 2011 11:56 AM | No Comments

Help Us Learn More About Myeloma Patients

Gala 2011 Press and Media

By IMF Admin on September 18, 2011 11:12 AM | No Comments

Gala 2011 Press and Media

Gala 2011 Advertising & Sponsorship Opportunities

By IMF Admin on September 18, 2011 11:12 AM | No Comments

Gala 2011 Advertising & Sponsorship Opportunities

Gala 2011 Tickets

By IMF Admin on September 18, 2011 11:12 AM | No Comments

Gala 2011 Tickets

Gala 2011 Event Sponsors

By IMF Admin on September 18, 2011 11:12 AM | No Comments

Gala 2011 Event Sponsors

Webcast of Dr. Meryl Beksac at ASH 2005

By IMF Admin on September 18, 2011 11:02 AM | No Comments

Webcast of Dr. Meryl Beksac at ASH 2005

JC?s Support for Myeloma Patients Grows

By IMF Admin on September 18, 2011 10:44 AM | No Comments

JC?s Support for Myeloma Patients Grows

February 26, 2002: IMF Myeloma Minute

By IMF Admin on September 18, 2011 10:28 AM | No Comments

February 26, 2002: IMF Myeloma Minute

12/13/01 IMF Myeloma Minute

By IMF Admin on September 18, 2011 10:26 AM | No Comments

12/13/01 IMF Myeloma Minute

testing

By IMF Admin on September 18, 2011 10:08 AM | No Comments

testing

The Page You Requested Is Not Available

By IMF Admin on September 18, 2011 9:51 AM | No Comments

The Page You Requested Is Not Available

AMEN Seminar for Hematology Residents

By IMF Admin on September 17, 2011 11:39 PM | No Comments

AMEN Seminar for Hematology Residents

What's New In Research - January 8, 2003

By IMF Admin on September 17, 2011 7:05 AM | No Comments

What's New In Research - January 8, 2003

What is the International Myeloma Working Group?

By IMF Admin on September 17, 2011 6:50 AM | No Comments

What is the International Myeloma Working Group?

July 16, 2002 IMF Myeloma Minute

By IMF Admin on September 16, 2011 8:27 AM | No Comments

July 16, 2002 IMF Myeloma Minute

Tim McElwain Travel Grants

By IMF Admin on September 16, 2011 8:25 AM | No Comments

Tim McElwain Travel Grants

Michael S. Katz, MBA

By IMF Admin on September 16, 2011 8:13 AM | No Comments

Michael S. Katz, MBA

Don Friedel

By IMF Admin on September 15, 2011 10:08 PM | No Comments

Don Friedel

Coming Soon: IMF Myeloma Manager Patient Flow Sheet

By IMF Admin on September 15, 2011 6:55 PM | No Comments

Coming Soon: IMF Myeloma Manager Patient Flow Sheet

Sydney 2005: Tumour Lysate Dendritic Cell Vaccination in Multiple Myeloma

By IMF Admin on September 15, 2011 2:58 AM | No Comments

Sydney 2005: Tumour Lysate Dendritic Cell Vaccination in Multiple Myeloma

NIH Announces Program to Foster the Independence of New Investigators

By IMF Admin on September 14, 2011 10:48 PM | No Comments

NIH Announces Program to Foster the Independence of New Investigators

What's New in Research - October 8, 2002

By IMF Admin on September 14, 2011 9:06 PM | No Comments

What's New in Research - October 8, 2002

March 12, 2003 Myeloma Minute

By IMF Admin on September 14, 2011 9:05 PM | No Comments

March 12, 2003 Myeloma Minute

Kathy Pedersen

By IMF Admin on September 14, 2011 9:03 PM | No Comments

Kathy Pedersen

Pictures from the Philadelphia Patient and Family Seminar - October 17-18, 2003

By IMF Admin on September 14, 2011 8:45 PM | No Comments

Pictures from the Philadelphia Patient and Family Seminar - October 17-18, 2003

Sydney 2005:
Drug Resistance in Multiple Myeloma

By IMF Admin on September 14, 2011 8:36 PM | No Comments

Sydney 2005:
Drug Resistance in Multiple Myeloma

Module 1: Screening, Diagnosis, and Staging of Multiple Myeloma

By IMF Admin on September 14, 2011 7:28 PM | No Comments

Module 1: Screening, Diagnosis, and Staging of Multiple Myeloma

May 14, 2002: IMF Myeloma Minute

By IMF Admin on September 14, 2011 7:28 PM | No Comments

May 14, 2002: IMF Myeloma Minute

testing pommo system for minute...

By IMF Admin on September 14, 2011 7:26 PM | No Comments

testing pommo system for minute...

One Voice Against Cancer Advocacy Training in Los Angeles
February 21, 2004

By IMF Admin on September 14, 2011 7:23 PM | No Comments

One Voice Against Cancer Advocacy Training in Los Angeles
February 21, 2004

Sydney 2005: In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase inhibitor, CYC202..

By IMF Admin on September 14, 2011 7:11 PM | No Comments

Sydney 2005: In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase inhibitor, CYC202..

January 16, 2003 Myeloma Minute

By IMF Admin on September 14, 2011 3:10 PM | No Comments

January 16, 2003 Myeloma Minute

Charles "Chuck" Thompson

By IMF Admin on September 14, 2011 3:09 PM | No Comments

Charles "Chuck" Thompson

TRATAMIENTO INICIAL O DE PRIMERA L

By IMF Admin on September 14, 2011 12:27 PM | No Comments

TRATAMIENTO INICIAL O DE PRIMERA L

TRATAMIENTO DE SOPORTE

By IMF Admin on September 14, 2011 3:50 AM | No Comments

TRATAMIENTO DE SOPORTE

Jacklyn Inman

By IMF Admin on September 14, 2011 2:56 AM | No Comments

Jacklyn Inman

Back by Popular Demand! The Myeloma Quilt of Courage!

By IMF Admin on September 14, 2011 2:55 AM | No Comments

IMF Urges Medicare to Add Thalidomide to Demonstration Project

By IMF Admin on September 14, 2011 2:50 AM | No Comments

IMF Urges Medicare to Add Thalidomide to Demonstration Project

testing

By IMF Admin on September 14, 2011 1:36 AM | No Comments

testing

Myeloma Awareness Week 2003 - August 10-17

By IMF Admin on September 14, 2011 1:33 AM | No Comments

Myeloma Awareness Week 2003 - August 10-17

IMF Myeloma Minute: July 2, 2002

By IMF Admin on September 14, 2011 1:32 AM | No Comments

IMF Myeloma Minute: July 2, 2002

What's New In Research - May 23, 2003

By IMF Admin on September 14, 2011 1:26 AM | No Comments

What's New In Research - May 23, 2003

July 26, 2003 Myeloma Minute

By IMF Admin on September 13, 2011 11:58 PM | No Comments

July 26, 2003 Myeloma Minute

IMF Myeloma Minute

By IMF Admin on September 13, 2011 11:52 PM | No Comments

IMF Myeloma Minute

February 14, 2002: IMF Myeloma Minute

By IMF Admin on September 13, 2011 7:00 PM | No Comments

February 14, 2002: IMF Myeloma Minute

A Phase 3 Trial of Kyphoplasty Versus Nonsurgical Care for Cancer Patients with Vertebral Fractures

By IMF Admin on September 13, 2011 6:14 PM | No Comments

A Phase 3 Trial of Kyphoplasty Versus Nonsurgical Care for Cancer Patients with Vertebral Fractures

Over 200 Attend 2nd Annual Patient & Family Seminar in Madrid

By IMF Admin on September 13, 2011 3:47 PM | No Comments

Over 200 Attend 2nd Annual Patient & Family Seminar in Madrid

Phase I VELCADE® Clinical Trials

By IMF Admin on September 13, 2011 3:42 PM | No Comments

Phase I VELCADE® Clinical Trials

Senate Passes Funding Bill; Includes Money for Myeloma Community

By IMF Admin on September 13, 2011 12:57 PM | No Comments

Senate Passes Funding Bill; Includes Money for Myeloma Community

Past Recipients of the Robert A. Kyle Lifetime Achievement Award

By IMF Admin on September 13, 2011 12:56 PM | No Comments

Past Recipients of the Robert A. Kyle Lifetime Achievement Award

Lem Hill

By IMF Admin on September 13, 2011 12:09 PM | No Comments

Lem Hill

Myeloma Minute Special ASH Update #1

By IMF Admin on September 13, 2011 12:08 PM | No Comments

Myeloma Minute Special ASH Update #1

George Burroughs

By IMF Admin on September 13, 2011 9:46 AM | No Comments

George Burroughs

June 18, 2002: IMF Myeloma Minute

By IMF Admin on September 13, 2011 9:26 AM | No Comments

June 18, 2002: IMF Myeloma Minute

What's New In Research - September 12, 2003

By IMF Admin on September 13, 2011 9:07 AM | No Comments

What's New In Research - September 12, 2003

Dr. Gertz - Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization

By IMF Admin on September 13, 2011 8:14 AM | No Comments

Dr. Gertz - Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization

Fonseca

By IMF Admin on September 13, 2011 8:11 AM | No Comments

Fonseca

Edyth Henderson

By IMF Admin on September 13, 2011 1:30 AM | No Comments

Edyth Henderson

Phase II THALOMID® Clinical Trials

By IMF Admin on September 12, 2011 8:16 PM | No Comments

Phase II THALOMID® Clinical Trials

IMF Announces 2002 Research Grant Recipients

By IMF Admin on September 12, 2011 8:15 PM | No Comments

IMF Announces 2002 Research Grant Recipients

Senate hearing on Blood Cancer Research

By IMF Admin on September 12, 2011 8:11 PM | No Comments

Senate hearing on Blood Cancer Research

Rafael Fonseca, M.D.

By IMF Admin on September 12, 2011 8:10 PM | No Comments

Rafael Fonseca, M.D.

What's New In Research - February 19, 2003

By IMF Admin on September 12, 2011 5:25 PM | No Comments

What's New In Research - February 19, 2003

Phase I Study of Elotuzumab (HuLuc63) in Combination with Bortezomib in Relapsed Multiple Myeloma

By IMF Admin on September 12, 2011 5:22 PM | No Comments

Phase I Study of Elotuzumab (HuLuc63) in Combination with Bortezomib in Relapsed Multiple Myeloma

EntreMed Thalidomide Analog Demonstrates Further Progress

By IMF Admin on September 12, 2011 5:20 PM | No Comments

EntreMed Thalidomide Analog Demonstrates Further Progress

Don Biddison

By IMF Admin on September 12, 2011 5:20 PM | No Comments

Don Biddison

November 19, 2002 IMF Myeloma Minute

By IMF Admin on September 12, 2011 5:09 PM | No Comments

November 19, 2002 IMF Myeloma Minute

June 11, 2003 Myeloma Minute

By IMF Admin on September 12, 2011 3:42 PM | No Comments

June 11, 2003 Myeloma Minute

1070

By IMF Admin on September 12, 2011 12:08 PM | No Comments

1070

Peter Randlov

By IMF Admin on September 12, 2011 11:26 AM | No Comments

Peter Randlov

Allogeneic and Autologous Transplantation

By IMF Admin on September 12, 2011 10:19 AM | No Comments

Allogeneic and Autologous Transplantation

Rockin' the Night Away!
The Ribbon of Hope Gala in Seattle 2003

By IMF Admin on September 12, 2011 10:09 AM | No Comments

Rockin' the Night Away!
The Ribbon of Hope Gala in Seattle 2003

Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

By IMF Admin on September 12, 2011 9:56 AM | No Comments

Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

Advocacy Update: Senators Outraged by Decreased Research Funding

By IMF Admin on September 12, 2011 5:19 AM | No Comments

Advocacy Update: Senators Outraged by Decreased Research Funding

December 11, 2002 Myeloma Minute

By IMF Admin on September 12, 2011 5:06 AM | No Comments

December 11, 2002 Myeloma Minute

Past Professional Meetings

By IMF Admin on September 12, 2011 3:48 AM | No Comments

Past Professional Meetings

Learn Why the IMF is Supporting OVAC Advocacy Days

By IMF Admin on September 12, 2011 3:25 AM | No Comments

Learn Why the IMF is Supporting OVAC Advocacy Days

IMF Japan Petitions The Ministry Of Labor & Welfare for Approval of Thalidomide and Velcade

By IMF Admin on September 11, 2011 11:19 PM | No Comments

IMF Japan Petitions The Ministry Of Labor & Welfare for Approval of Thalidomide and Velcade

rbarrow

By IMF Admin on September 11, 2011 10:04 PM | No Comments

rbarrow

Celebrating a Life

By IMF Admin on September 11, 2011 9:28 PM | No Comments

Celebrating a Life

Asociación de Enfermos de Mieloma

By IMF Admin on September 11, 2011 1:51 PM | No Comments

Asociación de Enfermos de Mieloma

Joel Harris

By IMF Admin on September 11, 2011 5:55 AM | No Comments

Joel Harris

Myeloma Minute Subscription

By IMF Admin on September 11, 2011 4:42 AM | No Comments

Myeloma Minute Subscription

Melvyn

By IMF Admin on September 11, 2011 3:30 AM | No Comments

Melvyn

Medicare Changes Impact Care

By IMF Admin on September 11, 2011 1:18 AM | No Comments

Medicare Changes Impact Care

Barb H.

By IMF Admin on September 10, 2011 5:45 PM | No Comments

Barb H.

Bill Otterson

By IMF Admin on September 10, 2011 5:41 PM | No Comments

Bill Otterson

What's New In Research - February 12, 2004

By IMF Admin on September 10, 2011 5:40 PM | No Comments

What's New In Research - February 12, 2004

THE 10 STEPS TO BETTER CARE

By IMF Admin on September 10, 2011 5:03 PM | No Comments

THE 10 STEPS TO BETTER CARE

Myeloma Minute

By IMF Admin on September 10, 2011 3:31 PM | No Comments

Myeloma Minute

IF FRONTLINE THERAPY IS NOT WORKING

By IMF Admin on September 10, 2011 2:56 PM | No Comments

IF FRONTLINE THERAPY IS NOT WORKING

International Myeloma Foundation - Thalidomide Insurance Survey

By IMF Admin on September 10, 2011 2:16 PM | No Comments

International Myeloma Foundation - Thalidomide Insurance Survey

Environment Editorial

By IMF Admin on September 10, 2011 8:33 AM | No Comments

Environment Editorial

December 23, 2003 Myeloma Minute

By IMF Admin on September 10, 2011 2:06 AM | No Comments

December 23, 2003 Myeloma Minute

January 29, 2003 Myeloma Minute

By IMF Admin on September 10, 2011 1:53 AM | No Comments

January 29, 2003 Myeloma Minute

Upcoming Professional Meetings

By IMF Admin on September 9, 2011 9:49 PM | No Comments

Upcoming Professional Meetings

Warren Harre

By IMF Admin on September 9, 2011 4:04 PM | No Comments

Warren Harre

OVAC 2002 Advocacy Day Senate Hearing: Written Testimony of Susie Novis

By IMF Admin on September 9, 2011 2:28 PM | No Comments

OVAC 2002 Advocacy Day Senate Hearing: Written Testimony of Susie Novis

May 2, 2003 Myeloma Minute

By IMF Admin on September 9, 2011 2:28 PM | No Comments

May 2, 2003 Myeloma Minute

IMFer Mike Katz Receives Award For Work As An FDA Patient Consultant

By IMF Admin on September 9, 2011 2:17 PM | No Comments

IMFer Mike Katz Receives Award For Work As An FDA Patient Consultant

Fourth Annual Robert A. Kyle Lifetime Achievement Award Tribute Journal

By IMF Admin on September 9, 2011 1:53 PM | No Comments

Fourth Annual Robert A. Kyle Lifetime Achievement Award Tribute Journal

Angiogenesis In Multiple Myeloma

By IMF Admin on September 9, 2011 12:56 PM | No Comments

Angiogenesis In Multiple Myeloma

ASH 2001 Coporate Friday: Advances In Multiple Myeloma Pathogenesis And Treatment

By IMF Admin on September 9, 2011 12:39 PM | No Comments

ASH 2001 Coporate Friday: Advances In Multiple Myeloma Pathogenesis And Treatment

Regis Battaile, MD

By IMF Admin on September 9, 2011 11:32 AM | No Comments

Regis Battaile, MD

Medicare Proposals Threaten Access to Care

By IMF Admin on September 9, 2011 8:19 AM | No Comments

Medicare Proposals Threaten Access to Care

Research Participants Sought

By IMF Admin on September 9, 2011 5:15 AM | No Comments

Research Participants Sought

Guidelines for the Diagnosis & Management of Multiple Myeloma

By IMF Admin on September 9, 2011 5:14 AM | No Comments

Guidelines for the Diagnosis & Management of Multiple Myeloma

Millennium Announces New Phase III PS-341 Trials

By IMF Admin on September 9, 2011 5:13 AM | No Comments

Millennium Announces New Phase III PS-341 Trials

November 9, 2003 Myeloma Minute

By IMF Admin on September 9, 2011 4:39 AM | No Comments

November 9, 2003 Myeloma Minute

September 14, 2003 Myeloma Minute

By IMF Admin on September 9, 2011 4:39 AM | No Comments

September 14, 2003 Myeloma Minute

Management of Anemia in Multiple Myeloma Patients with Anemia: Findings from the A.C.T. Study

By IMF Admin on September 9, 2011 4:26 AM | No Comments

Management of Anemia in Multiple Myeloma Patients with Anemia: Findings from the A.C.T. Study

Immunotherapies and Control Of Residual Disease

By IMF Admin on September 9, 2011 12:02 AM | No Comments

Immunotherapies and Control Of Residual Disease

Call Congress on April 8 to Support OVAC Agenda

By IMF Admin on September 9, 2011 12:01 AM | No Comments

Call Congress on April 8 to Support OVAC Agenda

Clinical Trials Listing from Acurian

By IMF Admin on September 8, 2011 11:05 PM | No Comments

Clinical Trials Listing from Acurian

August 9, 2003 Myeloma Minute

By IMF Admin on September 8, 2011 11:01 PM | No Comments

August 9, 2003 Myeloma Minute

Barisa's Test

By IMF Admin on September 8, 2011 9:56 PM | No Comments

Barisa's Test

KOS 2007: Serum Concentrations of Angiogenic Cytokines in Waldenstrom's Macroglobulinemia: The Ratio of Angiopoietin-1 to Angiopoietin-2 Correlate with Disease Severity

By IMF Admin on September 8, 2011 7:10 PM | No Comments

KOS 2007: Serum Concentrations of Angiogenic Cytokines in Waldenstrom's Macroglobulinemia: The Ratio of Angiopoietin-1 to Angiopoietin-2 Correlate with Disease Severity

Complete Response Rate and Patient Survival Data for STR Presented at ASH

By IMF Admin on September 8, 2011 6:40 PM | No Comments

Complete Response Rate and Patient Survival Data for STR Presented at ASH

Myeloma Manager™ News

By IMF Admin on September 8, 2011 6:11 PM | 2 Comments

Myeloma Manager™ News

Improving Options For Frontline Management Of Multiple Myeloma

By IMF Admin on September 8, 2011 6:09 PM | No Comments

Improving Options For Frontline Management Of Multiple Myeloma

Dear Members of the IMF Community

By IMF Admin on September 8, 2011 6:02 PM | No Comments

Dear Members of the IMF Community

What's New In Research - July 17, 2003

By IMF Admin on September 8, 2011 4:31 PM | No Comments

What's New In Research - July 17, 2003

DNA DSBs induction by Zalypsis, a novel marine compound, results in potent antimyeloma activity

By IMF Admin on September 8, 2011 3:33 PM | No Comments

DNA DSBs induction by Zalypsis, a novel marine compound, results in potent antimyeloma activity

International Myeloma Working Group

By IMF Admin on September 8, 2011 3:16 PM | No Comments

International Myeloma Working Group

What's New in Research - September 24, 2002

By IMF Admin on September 8, 2011 1:44 PM | No Comments

What's New in Research - September 24, 2002

An American in Paris?

By IMF Admin on September 8, 2011 11:31 AM | No Comments

An American in Paris?

August 24, 2003 Myeloma Minute

By IMF Admin on September 8, 2011 6:18 AM | No Comments

August 24, 2003 Myeloma Minute

John Nesci

By IMF Admin on September 8, 2011 12:54 AM | No Comments

John Nesci

September 10,2001 Myeloma Minute

By IMF Admin on September 7, 2011 6:49 PM | No Comments

September 10,2001 Myeloma Minute

April 4, 2003 Myeloma Minute

By IMF Admin on September 7, 2011 6:23 PM | No Comments

April 4, 2003 Myeloma Minute

Early Clinical Results Suggest Genasense(TM) May Be Useful for Patients With Highly Resistant MM

By IMF Admin on September 7, 2011 6:23 PM | No Comments

Early Clinical Results Suggest Genasense(TM) May Be Useful for Patients With Highly Resistant MM

What's New In Research - May 16, 2003

By IMF Admin on September 7, 2011 6:23 PM | No Comments

What's New In Research - May 16, 2003

February 7, 2002: IMF Myeloma Minute

By IMF Admin on September 7, 2011 4:40 PM | No Comments

February 7, 2002: IMF Myeloma Minute

New Phase II trial opens with VELCADE as front-line therapy

By IMF Admin on September 7, 2011 3:54 PM | No Comments

New Phase II trial opens with VELCADE as front-line therapy

April 16, 2002 IMF Myeloma Minute

By IMF Admin on September 7, 2011 1:49 PM | No Comments

April 16, 2002 IMF Myeloma Minute

The IMF is blogging from the XIIth International Myeloma Workshop in Washington, DC!

By IMF Admin on September 7, 2011 8:22 AM | No Comments

The IMF is blogging from the XIIth International Myeloma Workshop in Washington, DC!

Important New Blood Cancer Initiative Announced on Capital Hill

By IMF Admin on September 7, 2011 8:12 AM | No Comments

Important New Blood Cancer Initiative Announced on Capital Hill

A Brief History of the IMF

By IMF Admin on September 7, 2011 8:06 AM | No Comments

A Brief History of the IMF

testing ifbyphone link

By IMF Admin on September 7, 2011 8:05 AM | No Comments

testing ifbyphone link

IMF Presents Research Triple Play at Xth International Myeloma Workshop

By IMF Admin on September 7, 2011 5:39 AM | No Comments

IMF Presents Research Triple Play at Xth International Myeloma Workshop

Monoclonal Gammopathy of Undetermined Significance: Robert A. Kyle, MD

By IMF Admin on September 7, 2011 5:38 AM | No Comments

Monoclonal Gammopathy of Undetermined Significance: Robert A. Kyle, MD

Over 300 In Attendance at Third Italian Patient & Family Seminar

By IMF Admin on September 7, 2011 3:52 AM | No Comments

Over 300 In Attendance at Third Italian Patient & Family Seminar

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Mellqvist - Improved progression free survival with bortezomib consolidation after high dose melphalan; results of a randomized phase III trial

By IMF Admin on September 7, 2011 2:38 AM | No Comments

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Mellqvist - Improved progression free survival with bortezomib consolidation after high dose melphalan; results of a randomized phase III trial

Roz Jarrett

By IMF Admin on September 7, 2011 12:41 AM | No Comments

Roz Jarrett

Sponsorship Opportunities for the Fourth Annual Robert A. Kyle Lifetime Achievement Award

By IMF Admin on September 7, 2011 12:40 AM | No Comments

Sponsorship Opportunities for the Fourth Annual Robert A. Kyle Lifetime Achievement Award

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Zamagni - Prognostic relevance of 18F-FDG PET/CT in newly diagnosed Multiple Myeloma patients receiving up-front autologous stem-cell transplantation (ASCT): a prospective study

By IMF Admin on September 6, 2011 11:19 PM | No Comments

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Zamagni - Prognostic relevance of 18F-FDG PET/CT in newly diagnosed Multiple Myeloma patients receiving up-front autologous stem-cell transplantation (ASCT): a prospective study

Roger Neilson Editorial

By IMF Admin on September 6, 2011 8:45 PM | No Comments

Roger Neilson Editorial

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Richardson - A phase 1/2 multi-center, randomized, open label dose escalation study to determine the maximum tolerated dose (MTD), safety, and efficacy of pomalidomide (POM) alo

By IMF Admin on September 6, 2011 6:56 PM | No Comments

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Richardson - A phase 1/2 multi-center, randomized, open label dose escalation study to determine the maximum tolerated dose (MTD), safety, and efficacy of pomalidomide (POM) alone or in combination with low-dose dexamethasone (DEX) in patients (PTS) with relapsed and refractory Multiple Myeloma (RRMM) who have received prior treatment (TX) that includes lenalidomide (LEN) and bortezomib (BORT)

Testing event calendar

By IMF Admin on September 6, 2011 6:13 PM | No Comments

Testing event calendar

Cancer Trials Support Unit (CTSU)

By IMF Admin on September 6, 2011 4:27 PM | No Comments

Cancer Trials Support Unit (CTSU)

Myelom Merkur

By IMF Admin on September 6, 2011 3:31 PM | No Comments

Myelom Merkur

Arnold Gassan

By IMF Admin on September 6, 2011 3:00 PM | 2 Comments

Arnold Gassan

Phase III VELCADE® Clinical Trials

By IMF Admin on September 6, 2011 2:04 PM | No Comments

Phase III VELCADE® Clinical Trials

October 29, 2002 IMF Myeloma Minute

By IMF Admin on September 6, 2011 12:53 PM | No Comments

October 29, 2002 IMF Myeloma Minute

January 17, 2002: IMF Myeloma Minute

By IMF Admin on September 6, 2011 12:23 PM | No Comments

January 17, 2002: IMF Myeloma Minute

What's New In Research - November 1, 2003

By IMF Admin on September 6, 2011 11:51 AM | No Comments

What's New In Research - November 1, 2003

January 29, 2004 Myeloma Minute

By IMF Admin on September 6, 2011 9:01 AM | No Comments

January 29, 2004 Myeloma Minute

Facts About Zometa

By IMF Admin on September 6, 2011 8:19 AM | No Comments

Facts About Zometa

Florida Advocate Seeks Support of HR 2746

By IMF Admin on September 6, 2011 4:06 AM | No Comments

Florida Advocate Seeks Support of HR 2746

My Journey Through Myeloma

By IMF Admin on September 6, 2011 4:03 AM | No Comments

My Journey Through Myeloma

7th Annual JC Golf Tournament a Stellar Success!

By IMF Admin on September 6, 2011 4:01 AM | No Comments

7th Annual JC Golf Tournament a Stellar Success!

Complete Response As A Marker Of Patient Outcomes

By IMF Admin on September 5, 2011 4:19 PM | No Comments

Complete Response As A Marker Of Patient Outcomes

Report from the Sixth Annual Support Group Leaders' Retreat
July 8-10, 2005

By IMF Admin on September 5, 2011 4:18 PM | No Comments

Report from the Sixth Annual Support Group Leaders' Retreat
July 8-10, 2005

International Myeloma Foundation Celebrates Landmark Success of 2004

By IMF Admin on September 5, 2011 2:46 PM | No Comments

International Myeloma Foundation Celebrates Landmark Success of 2004

Defining the Disease

By IMF Admin on September 5, 2011 11:46 AM | No Comments

Defining the Disease

Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)

By IMF Admin on September 5, 2011 11:46 AM | No Comments

Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)

Carfilzomib in Patients with Relapsed Multiple Myeloma (PX-171-004)

By IMF Admin on September 5, 2011 11:46 AM | No Comments

Carfilzomib in Patients with Relapsed Multiple Myeloma (PX-171-004)

John Gibson, M.D., Ph.D.

By IMF Admin on September 5, 2011 11:44 AM | No Comments

John Gibson, M.D., Ph.D.

Oral Drug Bill Update

By IMF Admin on September 5, 2011 10:54 AM | No Comments

Oral Drug Bill Update

June 19, 2003 Myeloma Minute

By IMF Admin on September 5, 2011 9:44 AM | No Comments

June 19, 2003 Myeloma Minute

ASH 2004 Webcast

By IMF Admin on September 5, 2011 9:35 AM | No Comments

ASH 2004 Webcast

August 27, 2002 IMF Myeloma Minute

By IMF Admin on September 5, 2011 7:43 AM | No Comments

August 27, 2002 IMF Myeloma Minute

APEX

By IMF Admin on September 5, 2011 6:51 AM | No Comments

APEX

February 20, 2003 Myeloma Minute

By IMF Admin on September 5, 2011 6:47 AM | No Comments

February 20, 2003 Myeloma Minute

Myeloma Quilt of Courage #2 - Jean Willard

By IMF Admin on September 5, 2011 6:46 AM | No Comments

Myeloma Quilt of Courage #2 - Jean Willard

Thalidomide Insurance Survey

By IMF Admin on September 5, 2011 6:46 AM | No Comments

Thalidomide Insurance Survey

Moncolonal Antibody Directed Immunotherapy For The Treatment Of Multiple Myeloma

By IMF Admin on September 4, 2011 6:17 PM | No Comments

Moncolonal Antibody Directed Immunotherapy For The Treatment Of Multiple Myeloma

Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

By IMF Admin on September 4, 2011 5:53 AM | No Comments

Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

What a Night! Report from the IMF's 16th Anniversary Gala

By IMF Admin on September 4, 2011 5:52 AM | No Comments

What a Night! Report from the IMF's 16th Anniversary Gala

Myeloma Minute - June 20, 2004

By IMF Admin on September 4, 2011 1:41 AM | No Comments

Myeloma Minute - June 20, 2004

ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma

By IMF Admin on September 3, 2011 10:11 AM | No Comments

ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma

What's New In Research - August 22, 2003

By IMF Admin on September 3, 2011 6:35 AM | No Comments

What's New In Research - August 22, 2003

Monoclonal Gammopathy of Undetermined Significance (MGUS) References

By IMF Admin on September 3, 2011 3:56 AM | No Comments

Monoclonal Gammopathy of Undetermined Significance (MGUS) References

Congressional Appropriations Committees Act: Senate Approves Funding for Ferraro Education Program

By IMF Admin on September 3, 2011 1:00 AM | No Comments

Congressional Appropriations Committees Act: Senate Approves Funding for Ferraro Education Program

E. Michael D. Scott

By IMF Admin on September 2, 2011 11:21 PM | No Comments

E. Michael D. Scott

What's New In Research - March 25, 2003

By IMF Admin on September 2, 2011 10:51 PM | No Comments

What's New In Research - March 25, 2003

IMF ????? ????? ?????? ?? ????? ? - Revlimid

By IMF Admin on September 2, 2011 9:18 PM | No Comments

IMF ????? ????? ?????? ?? ????? ? - Revlimid

An old hometown needs help

By IMF Admin on September 2, 2011 9:08 PM | No Comments

An old hometown needs help

February 26, 2004 Myeloma Minute

By IMF Admin on September 2, 2011 9:07 PM | No Comments

February 26, 2004 Myeloma Minute

Myeloma Minute - July 27, 2004

By IMF Admin on September 2, 2011 9:07 PM | No Comments

Myeloma Minute - July 27, 2004

What's New In Research - October 13, 2003

By IMF Admin on September 2, 2011 9:06 PM | No Comments

What's New In Research - October 13, 2003

STEP 2 - REFERENCES

By IMF Admin on September 2, 2011 8:08 PM | No Comments

STEP 2 - REFERENCES

Living Well with Myeloma 2011 – Clinical Trials: Why they're important and why you should consider participating in one.

By IMF Admin on September 2, 2011 7:17 PM | No Comments

Living Well with Myeloma 2011 – Clinical Trials: Why they're important and why you should consider participating in one.

Audrey Thornton

By IMF Admin on September 2, 2011 5:10 PM | No Comments

Audrey Thornton

Access to Cancer Therapies Act, H.R. 1624 / S. 913, Medicare Coverage of Anti-Cancer Therapies

By IMF Admin on September 2, 2011 3:58 PM | No Comments

Access to Cancer Therapies Act, H.R. 1624 / S. 913, Medicare Coverage of Anti-Cancer Therapies

Aurora-kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma

By IMF Admin on September 2, 2011 1:15 PM | No Comments

Aurora-kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma

Medicare Deadline Reminder

By IMF Admin on September 2, 2011 9:44 AM | No Comments

Medicare Deadline Reminder

Phase II Multicenter Open Label Study of Single-Agent REVIMID

By IMF Admin on September 2, 2011 9:18 AM | No Comments

Phase II Multicenter Open Label Study of Single-Agent REVIMID

NCI's Strategic Plans for Addressing Recommendations of the LLM Progress Review Group

By IMF Admin on September 2, 2011 8:41 AM | No Comments

NCI's Strategic Plans for Addressing Recommendations of the LLM Progress Review Group

Expert Opinions On Multiple Myeloma

By IMF Admin on September 2, 2011 8:15 AM | No Comments

Expert Opinions On Multiple Myeloma

MY MMAMM EXPERIENCE

By IMF Admin on September 2, 2011 5:24 AM | No Comments

MY MMAMM EXPERIENCE

Patricia Meyer

By IMF Admin on September 2, 2011 3:23 AM | 2 Comments

Patricia Meyer

Combined Federal Campaign (CFC)

By IMF Admin on September 2, 2011 2:38 AM | No Comments

Combined Federal Campaign (CFC)

Phase II REVLIMID? Trials

By IMF Admin on September 2, 2011 1:46 AM | No Comments

Phase II REVLIMID? Trials

2009 Virtual Founders Summit

By IMF Admin on September 2, 2011 12:54 AM | No Comments

2009 Virtual Founders Summit

Sept. 3, 1999 -- VIIth International Myeloma Workshop, Stockholm Sweden

By IMF Admin on September 2, 2011 12:47 AM | No Comments

Sept. 3, 1999 -- VIIth International Myeloma Workshop, Stockholm Sweden

Fourth Annual Robert A. Kyle Lifetime Achievement Award Sponsors

By IMF Admin on September 2, 2011 12:16 AM | No Comments

Fourth Annual Robert A. Kyle Lifetime Achievement Award Sponsors

The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011

By IMF Admin on September 1, 2011 8:56 PM | No Comments

The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011

Gene McLaughlin

By IMF Admin on September 1, 2011 8:43 PM | No Comments

Gene McLaughlin

December 3, 2002 Myeloma Minute

By IMF Admin on September 1, 2011 8:18 PM | No Comments

December 3, 2002 Myeloma Minute

Dendiric Cell-Based Vaccination With Idiotype For Amyloidosis And Post-Transplant Myeloma

By IMF Admin on September 1, 2011 8:16 PM | No Comments

Dendiric Cell-Based Vaccination With Idiotype For Amyloidosis And Post-Transplant Myeloma

November 16, 2003 Myeloma Minute

By IMF Admin on September 1, 2011 8:16 PM | No Comments

November 16, 2003 Myeloma Minute

San Diego Patient & Family Seminar a Sold Out Success

By IMF Admin on September 1, 2011 7:05 PM | No Comments

San Diego Patient & Family Seminar a Sold Out Success

What's New In Research - November 24, 2003

By IMF Admin on September 1, 2011 7:05 PM | No Comments

What's New In Research - November 24, 2003

IMF

By IMF Admin on September 1, 2011 7:04 PM | No Comments

IMF

Ronnie MacIntyre

By IMF Admin on September 1, 2011 6:29 PM | No Comments

Ronnie MacIntyre

Mario Ranelli

By IMF Admin on September 1, 2011 6:24 PM | No Comments

Mario Ranelli

Myeloma Quilt of Courage #2 - The IMF

By IMF Admin on September 1, 2011 6:12 PM | No Comments

Myeloma Quilt of Courage #2 - The IMF

Advocacy Update

By IMF Admin on September 1, 2011 4:21 PM | No Comments

Advocacy Update

Multiple Colors for Multiple Myeloma

By IMF Admin on September 1, 2011 3:20 PM | No Comments

Multiple Colors for Multiple Myeloma

Multiple Myeloma Quilt of Courage #5 - To Honor Tom Finnerty

By IMF Admin on September 1, 2011 3:19 PM | No Comments

Multiple Myeloma Quilt of Courage #5 - To Honor Tom Finnerty

Myeloma Minute

By IMF Admin on September 1, 2011 2:52 PM | No Comments

Myeloma Minute

UPDATE - Study of Homing Mechanisms Involved in the Biology of MM: Ivan Van Riet, Ph.D

By IMF Admin on September 1, 2011 2:52 PM | No Comments

UPDATE - Study of Homing Mechanisms Involved in the Biology of MM: Ivan Van Riet, Ph.D

October 8, 2002 IMF Myeloma Minute

By IMF Admin on September 1, 2011 2:52 PM | No Comments

October 8, 2002 IMF Myeloma Minute

September 24, 2002 IMF Myeloma Minute

By IMF Admin on September 1, 2011 2:51 PM | No Comments

September 24, 2002 IMF Myeloma Minute

What's New In Research - May 1, 2003

By IMF Admin on September 1, 2011 2:51 PM | No Comments

What's New In Research - May 1, 2003

Role of FISH in Myeloma Risk Stratification

By IMF Admin on September 1, 2011 2:49 PM | No Comments

Role of FISH in Myeloma Risk Stratification

STAGING & PROGNOSTIC CLASSIFICATION

By IMF Admin on September 1, 2011 1:40 PM | No Comments

STAGING & PROGNOSTIC CLASSIFICATION

Bob Rinker

By IMF Admin on September 1, 2011 11:08 AM | No Comments

Bob Rinker

Sept. 4, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden

By IMF Admin on September 1, 2011 9:03 AM | No Comments

Sept. 4, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden

September 2011 Archives : Discussions About IMF Web Site Content